{"mainPropery":{"diseaseId":1356,"diseaseName":"Neonatal Onset Multisystem Inflammatory disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1356/neonatal-onset-multisystem-inflammatory-disease","synonyms":["Chronic Infantile Neurological Cutaneous Articular syndrome","CINCA syndrome","CINCA","Infantile Onset Multisystem Inflammatory Disease","IOMID","NOMID","Multisystem inflammatory disease, neonatal-onset","Prieur Griscelli syndrome"],"synonyms-with-source":[{"name":"Chronic Infantile Neurological Cutaneous Articular syndrome","source":"Orphanet"},{"name":"CINCA syndrome"},{"name":"CINCA"},{"name":"Infantile Onset Multisystem Inflammatory Disease"},{"name":"IOMID"},{"name":"NOMID"},{"name":"Multisystem inflammatory disease, neonatal-onset"},{"name":"Prieur Griscelli syndrome"}],"identifiers":[{"identifierType":"OMIM","identifierId":"607115"},{"identifierType":"ORPHANET","identifierId":"1451"},{"identifierType":"UMLS","identifierId":"C0409818"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3600,"resourceName":"FMF & AID Global Association","abbreviation":"","address1":"Schüracherstrasse 25a","address2":"8306 Brüttisellen","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Switzerland","phone":"+41 76 415 4010","tty":"","tollFree":"","fax":"","email":"info@fmfandaid.org ","url":"https://www.fmfandaid.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/607115' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=607115' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neonatal Onset Multisystem Inflammatory disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Chronic+Infantile+Neurological+Cutaneous+Articular+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Neonatal Onset Multisystem Inflammatory disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=neonatalonsetmultisysteminflammatorydisease' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Neonatal Onset Multisystem Inflammatory disease. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/caps' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":720,"resourceId":1415,"resourceName":"Cryopyrin-Associated Periodic Syndromes_ full text article","descriptionText":"Leigh D Church, Sinisa Savic, and Michael F McDermott; <em><a href='http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=19707454 ' target='_blank'>Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap), </a></em>Biologics. <span class=\"citation-publication-date\">2008 December; </span><span class=\"citation-volume\">2</span><span class=\"citation-issue\">(4)</span><span class=\"citation-flpages\">: 733–742.</span>","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/neonatal-onset-multisystem-inflammatory-disease/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/952254-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=1451' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/topics/nomidcinca-syndrome/' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1552,"resourceId":2179,"resourceName":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","descriptionText":"The <a href='http://www.niams.nih.gov/' target='_blank'>National Institute of Arthritis and Musculoskeletal and Skin Diseases</a> (NIAMS) offers printed materials on this topic. We recommend calling toll-free at 877-226-4267 to request a copy of this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1562,"resourceId":2179,"resourceName":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","descriptionText":"The <a href='http://www.niams.nih.gov/Health_Info/Autoinflammatory/default.asp' target='_blank'>National Institute of Arthritis and Musculoskeletal and Skin Diseases</a> (NIAMS) support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:607115' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2260,"questionText":"What is neonatal onset multisystem inflammatory disease (NOMID)?","answerText":"<strong>Neonatal onset multisystem inflammatory disease (NOMID)</strong>&nbsp;is an inflammatory disorder present from birth (congenital) characterized by tissue damage of the nervous system, skin, and joints. Individuals with NOMID  have a skin rash that is present from birth and persists throughout life. Other symptoms may include: headaches, seizures, and vomiting resulting from chronic <a href=\"https://medlineplus.gov/meningitis.html\" target=\"_blank\">meningitis</a> (inflammation of the tissue that covers and protects the brain and spinal cord); intellectual disability; episodes of mild fever; and hearing and vision problems.[1393][12428] NOMID is the most severe form of the <a href=\"http://www.dermnetnz.org/topics/cryopyrin-associated-periodic-syndromes/\" target=\"_blank\">cryopyrin associated periodic syndromes</a> (CAPS) caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"https://ghr.nlm.nih.gov/gene/NLRP3\" target=\"_blank\">NLRP3</a></em>&nbsp;(<em>CIAS1</em>) gene. About 50% of affected individuals with NOMID are found to have mutations in this gene. This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;manner.[1394][12428] Treatment may include the use of medications to suppress the process of inflammation, such as anti-inflammatories, corticosteroids, and interleukin-1 beta receptors.[1394][12430]","dateModified":"2016-10-25T00:00:00"},"basicQuestions":[{"questionId":2261,"questionText":"What symptoms are associated with&nbsp;neonatal onset multisystem inflammatory disease (NOMID)?","answerText":"The symptoms of neonatal onset multisystem inflammatory disease (NOMID)&nbsp;start at birth, or are observed within the first weeks of life. The first symptoms are usually a skin rash and fever. Individuals with NOMID may also have  chronic <a href=\"http://www.nlm.nih.gov/medlineplus/meningitis.html\" target=\"_blank\">meningitis</a> (inflammation of the membranes surrounding the brain), which may lead to headaches, seizures, and vomiting. Hearing loss, vision loss, and intellectual disability, may also occur.<br />\r\n<br />\r\nPeople with NOMID often experience joint inflammation, swelling, and cartilage overgrowth, causing characteristic prominent knees and other skeletal abnormalities that worsen over time. Joint deformities called contractures may restrict the movement of certain joints.<br />\r\n<br />\r\nOther features of this disorder include short stature with shortening of the lower legs and forearms, and characteristic facial features, including a prominent forehead and protruding eyes. There is an increased risk for individuals with NOMID to develop abnormal deposits of a protein called amyloid (<a href=\"https://medlineplus.gov/amyloidosis.html\" target=\"_blank\">amyloidosis</a>), which may cause kidney damage.[12428][12430]","dateModified":"2016-10-25T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12428,"authors":"","articleTitle":"neonatal onset multisystem inflammatory disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2008","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/neonatal-onset-multisystem-inflammatory-disease#definition","dateAccessed":"2016-10-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12430,"authors":"","articleTitle":"NOMID/CINCA","bookWebsiteJournalTitle":"Autoinflammatory Alliance","date":"","volume":"","pages":"","url":"http://www.autoinflammatory.org/nomid.php","dateAccessed":"2016-10-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2262,"questionText":"What causes&nbsp;neonatal onset multisystem inflammatory disease (NOMID)?","answerText":"Neonatal onset multisystem inflammatory disease (NOMID) is a genetic disease, often caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"https://ghr.nlm.nih.gov/gene/NLRP3\" target=\"_blank\">NLRP3</a>&nbsp;(</em>also known as<em> CIAS1)&nbsp;</em>gene. In almost all cases, NOMID results from new mutations within this gene. These cases occur in people with no history of the disorder in their family (de novo). A few cases have been reported in which an affected person has inherited the mutation from one affected parent. In these instances, the disorder is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>  manner.[12428]<br />\r\n<br />\r\nThe <em>NLRP3 </em>gene provides instructions for making a protein called cryopyrin.  Cryopyrin is found mainly in white blood cells and in cartilage-forming cells (chondrocytes)&nbsp;and plays a role in the immune system, helping to start and regulate the immune system response.&nbsp;It is suspected that mutations within the <em>NLRP3</em> gene&nbsp;cause cryopyrin to be overactive, leading to an inappropriate inflammatory response that results the symptoms of in NOMID.[12428]&nbsp;<br />\r\n<br />\r\nA genetic mutation in the <em>NLRP3</em> gene is not found in about 50% of individuals with NOMID.[12428][12430]","dateModified":"2016-10-25T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":12428,"authors":"","articleTitle":"neonatal onset multisystem inflammatory disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2008","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/neonatal-onset-multisystem-inflammatory-disease#definition","dateAccessed":"2016-10-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12430,"authors":"","articleTitle":"NOMID/CINCA","bookWebsiteJournalTitle":"Autoinflammatory Alliance","date":"","volume":"","pages":"","url":"http://www.autoinflammatory.org/nomid.php","dateAccessed":"2016-10-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15513,"phenoTypeName":"Abnormality of neutrophils","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3056,"phenoTypeName":"Brachydactyly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14045,"phenoTypeName":"Elevated C-reactive protein level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6246,"phenoTypeName":"Elevated erythrocyte sedimentation rate","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14307,"phenoTypeName":"Increased intracranial pressure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8738,"phenoTypeName":"Meningitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13709,"phenoTypeName":"Migraine","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":957,"phenoTypeName":"Papule","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5645,"phenoTypeName":"Pseudopapilledema","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9144,"phenoTypeName":"Uveitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15511,"phenoTypeName":"Abnormal thrombocyte morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4062,"phenoTypeName":"Delayed closure of the anterior fontanelle","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8259,"phenoTypeName":"Edema","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13394,"phenoTypeName":"Frontal bossing","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5673,"phenoTypeName":"Joint dislocation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9804,"phenoTypeName":"Proptosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13279,"phenoTypeName":"Skeletal dysplasia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10089,"phenoTypeName":"Blindness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4082,"phenoTypeName":"Growth delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4771,"phenoTypeName":"Premature birth","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8268,"phenoTypeName":"Purpura","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10304,"phenoTypeName":"Reduced bone mineral density","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":142,"phenoTypeName":"Retrobulbar optic neuritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5670,"phenoTypeName":"Arthritis","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":11338,"phenoTypeName":"Progressive sensorineural hearing impairment","percentRanges":"-"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","percentRanges":"-"}],"medicalProducts":[{"productId":404,"genericName":"Rilonacept","tradeName":"Arcalyst","tradeLink":"https://www.arcalyst.com/","manufacturer":"","sponsor":"Regeneron Pharmaceuticals, Inc.","indication":"February 2008, rilonacept (Arcalyst) was approved for treatment of cryopyrin-assisted periodic syndromes (CAPS).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/arcalyst","medlinePlusLink":""},{"productId":557,"genericName":"Anakinra","tradeName":"Kineret","tradeLink":"https://www.kineretrx.com/nomid","manufacturer":"","sponsor":"Swedish Orphan Biovitrum AB; SOBI","indication":"December 2012, anakinra (Kineret) was approved for the treatment of neonatal-onset multisystem inflammatory disease (NOMID).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/kineret","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a602001.html"}],"EncodedName":"Neonatal_Onset_Multisystem_Inflammatory_disease"}